Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Disinfectant Effectiveness Testing Challenges

Carol Bartnett, James N. Polarine and David J. Shields
PDA Journal of Pharmaceutical Science and Technology January 2017, 71 (1) 59-65; DOI: https://doi.org/10.5731/pdajpst.2016.006700
Carol Bartnett
1STERIS, 7405 Page Avenue, St. Louis, MO 63133 and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James N. Polarine Jr.
1STERIS, 7405 Page Avenue, St. Louis, MO 63133 and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Shields
2Biotest Laboratories, Inc. a Subsidiary of STERIS, Brooklyn Park, MN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: david_shields@steris.com
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    GMP Trends Newsletter, Issue #931, November 1, 2015; GMP Trends, Inc.: Boulder, CO.
  2. 2.↵
    GMP Trends Newsletter, Issue #931, November 1, 2015; GMP Trends, Inc.: Boulder, CO.
  3. 3.↵
    GMP Trends Newsletter, Issue #923, July, 1 2015. Published by GMP Trends, Inc. Boulder, CO.
  4. 4.↵
    FDA Inspections Compliance, Enforcement and Criminal Investigations. Warning Letter, May 24, 2007. Available at http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2007/ucm076398.htm
  5. 5.
    General Information Chapter <1072> Disinfectants and Antiseptics. In United States Pharmacopoeia USP 38–NF 33; United States Pharmacopeial Convention/National Formulary: Rockville, MD, 2015.
  6. 6.
    European Committee for Standardization EN-13697:2015. Chemical Disinfectants and antiseptics—Quantitative non-porous surface test for the evaluation of bactericidal and/or fungicidal activity of chemical disinfectants used in food, industrial, domestic and institutional areas—Test method and requirements without mechanical action (phase 2, step 2). Available from British Standards Institute (BSI), 389 Chiswick High Rd., London W4AL, U.K.
  7. 7.
    PDA Technical Report No. 70. Fundamentals of Cleaning and Disinfection Programs for Aseptic Manufacturing Facilities. Parenteral Drug Association, Inc.: Bethesda, MD, 2015.
  8. 8.↵
    General Information Chapter <1227> Validation of Microbial Recovery from Pharmacopeial Articles. In United States Pharmacopoeia USP 38–NF 33; United States Pharmacopeial Convention/National Formulary: Rockville, MD, 2015.
  9. 9.↵
    1. Rutala W. A.,
    2. Weber D. J.
    ; Healthcare Infection Control Practices Advisory Committee. Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008; Centers for Disease Control and Prevention: Atlanta, GA, 2008. Available at http://www.cdc.gov/hicpac/Disinfection_Sterilization/acknowledg.html
  10. 10.↵
    1. Cerf O.,
    2. Metro F.
    Tailing of Survival Curves of Bacillus licheniformis Spores Treated with Hydrogen Peroxide. J. Appl. Bacteriol. 1977, 42 (3), 405–415.
    OpenUrlCrossRefPubMed
  11. 11.↵
    STERISCorporation. Unpublished data, 2016.
  12. 12.↵
    1. Hunsinger B.,
    2. Abele A.,
    3. Bohm R.
    Effects of the Drying Conditions on Different Gram Negative Bacteria on Stainless Steel Discs Used in the “Quantitative Surface Test for the Evaluation of Bactericidal Activity of Chemical Disinfectants” (EN 14349). XIIth International Congress on Animal Hygiene 2005, 2, 217–220. Available at http://www.isah-soc.org/index.php?action=17
  13. 13.↵
    1. Rohm-Rodowald E.,
    2. Chojecka A.,
    3. Jakimiak B.,
    4. Wiercinska O.,
    5. Ziemba B.,
    6. Kanclerski K.
    Effect of Different Drying Conditions for the Viability of Candida Albicans Present on Carriers. Annals of the National Institute of Hygiene 2014, 65 (1), 49–54. Available at: http://wydawnictwa.pzh.gov.pl/roczniki_pzh/roczniki-pzh-artykuly?year=2014&subissue=1
    OpenUrl
  14. 14.↵
    FDA Form 483, May 2–25, 2011. Available at http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm275843.pdf.
  15. 15.↵
    1. Brown R. W. B.,
    2. Gilbert P.
    Microbiological Quality Assurance: A Guide Towards, Relevance and Reproducibility of Inocula; CRC Press: Boca Raton, FL, 1995.
  16. 16.↵
    1. Sutton S. V. W.,
    2. Proud D. W.,
    3. Rachui S.,
    4. Brannan D. K.
    Validation of Microbial Recovery from Disinfectants. PDA J. Pharm. Sci. Technol. 2002, 56 (5), 255–266.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Salaman-Byron A.
    Bioburden Method Suitability for Cleaning and Sanitation Monitoring: How Far Do We Have to Go? Pharm. Technol. 2010, 34 (8). Available at: http://www.pharmtech.com
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 71 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 71, Issue 1
January/February 2017
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Disinfectant Effectiveness Testing Challenges
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Disinfectant Effectiveness Testing Challenges
Carol Bartnett, James N. Polarine, David J. Shields
PDA Journal of Pharmaceutical Science and Technology Jan 2017, 71 (1) 59-65; DOI: 10.5731/pdajpst.2016.006700

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Disinfectant Effectiveness Testing Challenges
Carol Bartnett, James N. Polarine, David J. Shields
PDA Journal of Pharmaceutical Science and Technology Jan 2017, 71 (1) 59-65; DOI: 10.5731/pdajpst.2016.006700
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Log Reduction Acceptance Criteria
    • General Causes
    • Inoculum
    • Surfaces
    • Neutralization
    • Recovery Method
    • Conclusion
    • Conflict of Interest Declaration
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • You "Like" Us!
  • Google Scholar

More in this TOC Section

  • Challenges and Solutions to Manufacturing of Low-Viscosity, Ultra-High Concentration IgG1 Drug Products: From Late Downstream Process to Final Fill Finish Processing
  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
  • Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
Show more Commentary

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire